The main focus of our study was to examine the association of tumor infiltrating CD4+CD25+FOXP3+ Tregs and other T cells with clinical outcome in epithelial ovarian cancer patients, since this approach of triple staining has not been done in ovarian tumors to the best of our knowledge. This evidence concerns the gene FOXP3 and ovarian carcinoma.